Skip to main content
GDRX $3.73 +0.27%
GDRX logo

GDRX · GoodRx Holdings, Inc.

Track GDRX — free
$3.73 +0.01 (+0.27%) At close · Aug 14
Market Cap
$1.27B
Shares
341.15M
All earnings calls

Earnings call · FY2026 Q2

GoodRx Holdings, Inc. Q2 FY2026 Earnings Call

GoodRx Holdings, Inc. Q2 FY2026 Earnings Call

Concluded Aug 5, 2026
Aug 5, 2026 0 turns
Period
FY2026 Q2
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $200.41M -1.3% YoY
Diluted EPS $0.02 -50% YoY
Net income $8.54M -33.5% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 5, 2026.

Metric Guided
Revenue table
FY 2026
$790M – $805M
Adjusted EBITDA table
FY 2026
$240M – $250M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Prescription Transactions Revenue$106.39M -25.6% YoY
Pharma Manufacturer Solutions Revenues$61.63M +76.2% YoY
Subscription Revenue$28.51M +39.3% YoY
Other Revenue$3.88M -15% YoY

Capital returned

Buybacks · derived
$1.95M
Full-screen source Call document